Skip to main navigation Skip to search Skip to main content

Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial

  • Amitkumar Mehta
  • , Leslie Popplewell
  • , Graham P. Collins
  • , Sonali M. Smith
  • , Ian W. Flinn
  • , Nancy L. Bartlett
  • , Nilanjan Ghosh
  • , Gal Hacohen-Kleiman
  • , Yanan Huo
  • , Linda Su-Feher
  • , Camille Renard
  • , Ranjana Advani
  • , Mark Roschewski

Research output: Contribution to journal › Article › peer-review

20   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science